CoChat

4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers

Open access
Larue, Ruben T.H.M., Van De Voorde, Lien, van Timmeren, Janna E., Leijenaar, Ralph T.H., Berbée, Maaike, Sosef, Meindert N., Schreurs, Wendy M.J., van Elmpt, Wouter, Lambin, Philippe · 2017 · Radiotherapy and Oncology
Cited by 75

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND PURPOSE: Quantitative tissue characteristics derived from medical images, also called radiomics, contain valuable prognostic information in several tumour-sites. The large number of features available increases the risk of overfitting. Typically test-retest CT-scans are used to reduce dimensionality and select robust features. However, these scans are not always available. We propose to use different phases of respiratory-correlated 4D CT-scans (4DCT) as alternative. MATERIALS AND METHODS: In test-retest CT-scans of 26 non-small cell lung cancer (NSCLC) patients and 4DCT-scans (8 breathing phases) of 20 NSCLC and 20 oesophageal cancer patients, 1045 radiomics features of the primary tumours were calculated. A concordance correlation coefficient (CCC) >0.85 was used to identify robust features. Correlation with prognostic value was tested using univariate cox regression in 120 oesophageal cancer patients. RESULTS: Features based on unfiltered images demonstrated greater robustness than wavelet-filtered features. In total 63/74 (85%) unfiltered features and 268/299 (90%) wavelet features stable in the 4D-lung dataset were also stable in the test-retest dataset. In oesophageal cancer 397/1045 (38%) features were robust, of which 108 features were significantly associated with overall-survival. CONCLUSION: 4DCT-scans can be used as alternative to eliminate unstable radiomics features as first step in a feature selection procedure. Feature robustness is tumour-site specific and independent of prognostic value.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2017.07.023

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 75

Metadata

Authors
Larue, R. T. H. M., Van De Voorde, L., van Timmeren, J. E., Leijenaar, R. T. H., Berbée, M., Sosef, M. N., Schreurs, W. M. J., van Elmpt, W., & Lambin, P.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2017-10
Volume
125
Issue
1
Pages
147-153
ISSN
0167-8140 (ISSN-L)
OpenAlex
W2734463838
Cited by
75
References
4
FWCI
6.63
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers. https://app.cochat.ai/papers/10.1016/j.radonc.2017.07.023
The paper
Larue, R. T. H. M., Van De Voorde, L., van Timmeren, J. E., Leijenaar, R. T. H., Berbée, M., Sosef, M. N., Schreurs, W. M. J., van Elmpt, W., & Lambin, P. (2017). 4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2017.07.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.